Reference health

Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study

https://doi.org/10.1093/rheumatology/kev348
CiteStamped reference-health badge
30/30 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

12 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 30 checked references that resolve
resolves10.1056/NEJMra011913
Polymyalgia Rheumatica and Giant-Cell Arteritis
resolves10.1038/nrrheum.2013.161
Immune mechanisms in medium and large-vessel vasculitis
resolves10.1016/S0002-9343(97)89458-2
Long-term survival of patients with giant cell arteritis in the american college of rheumatology giant cell arteritis classification criteria cohort
resolves10.1002/acr.21569
Incidence of infections in patients with giant cell arteritis: A cohort study
resolves10.1002/art.11388
Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
resolves10.1097/MD.0b013e31821c4fad
Relapses and Recurrences in Giant Cell Arteritis
resolves10.1097/MD.0000000000000033
Relapses in Patients With Giant Cell Arteritis
resolves10.1136/ard.2008.088351
EULAR recommendations for the management of large vessel vasculitis
resolves10.1002/art.10262
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
resolves10.1016/j.semarthrit.2013.10.009
Treatment with angiotensin II receptor blockers is associated with prolonged relapse-free survival, lower relapse rate, and corticosteroid-sparing effect in patients with giant cell arteritis
resolves10.1002/art.22163
Treatment of giant cell arteritis using induction therapy with high‐dose glucocorticoids: A double‐blind, placebo‐controlled, randomized prospective clinical trial
resolves10.1093/rheumatology/39.10.1089
Anticardiolipin antibody levels predict flares and relapses in patients with giant-cell (temporal) arteritis. A longitudinal study of 58 biopsy-proven cases
resolves10.1002/art1.10161
A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant‐cell arteritis
resolves10.6061/clinics/2013(03)OA06
Giant cell arteritis: a multicenter observational study in Brazil
resolves10.1007/s00296-012-2580-4
Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR)
resolves10.1093/rheumatology/kep395
Can the prognosis of polymyalgia rheumatica be predicted at disease onset? Results from a 5-year prospective study
resolves10.1136/ard.47.9.733
Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).
resolves10.3109/03009742.2013.793777
Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden
resolves10.3109/03009749309095141
Incidence and Survival Rate in Cases of Biopsy-proven Temporal Arteritis
resolves10.1002/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X
Giant cell arteritis and cardiovascular risk factors: A multicenter, prospective case-control study
resolves10.1093/ije/18.4.836
A Population-Based Case-Control Study of Temporal Arteritis: Evidence for an Association between Temporal Arteritis and Degenerative Vascular Disease?
resolves10.1097/01.md.0000145369.25558.b5
Influence of Traditional Risk Factors of Atherosclerosis in the Development of Severe Ischemic Complications in Giant Cell Arteritis
resolves10.1093/rheumatology/ken465
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis
resolves10.1136/ard.61.8.718
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology
resolves10.1016/j.semarthrit.2006.12.005
Influence of Previous Corticosteroid Therapy on Temporal Artery Biopsy Yield in Giant Cell Arteritis
resolves10.7326/0003-4819-120-12-199406150-00003
How Does Previous Corticosteroid Treatment Affect the Biopsy Findings in Giant Cell (Temporal) Arteritis?
resolves10.1016/S0025-6196(12)61373-1
Persistent Giant Cell Arteritis Despite Corticosteroid Treatment
resolves10.1161/CIRCULATIONAHA.109.872903
Th17 and Th1 T-Cell Responses in Giant Cell Arteritis
resolves10.1172/JCI119477
Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.
resolves10.1097/RHU.0b013e31823e2e35
Giant Cell Arteritis in Mexican Patients
The 12 references without a DOI — listed, not checked
no DOI — not checkedMortality in patients with giant cell arteritis
no DOI — not checkedGiant cell arteritis: intensity of the initial systemic inflammatory response and the course of the disease
no DOI — not checkedPrognostic factors and long-term evolution in a cohort of 133 patients with giant cell arteritis
no DOI — not checkedSex differences in temporal arteritis and polymyalgia rheumatica
no DOI — not checkedLongterm therapy in polymyalgia rheumatica: effect of coexistent temporal arteritis
no DOI — not checkedAnalysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients
no DOI — not checkedA randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients
no DOI — not checkedRestricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis
no DOI — not checkedSex differences in giant cell arteritis
no DOI — not checkedIncreased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden
no DOI — not checkedIschemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population based study
no DOI — not checkedEfficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1093/rheumatology/kev348"><img src="https://citestamp.com/citestamped/10.1093/rheumatology/kev348/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1093/rheumatology/kev348/badge.svg)](https://citestamp.com/citestamped/10.1093/rheumatology/kev348)